comparemela.com
Home
Live Updates
Joanne Wuensch Citi - Breaking News
Pages:
2
3
4
5
6
7
8
Latest Breaking News On - Joanne wuensch citi - Page 1 : comparemela.com
DexCom (DXCM) Q1 2024 Earnings Call Transcript
DXCM earnings call for the period ending March 31, 2024.
United states
United kingdom
Matt miksic barclays
Danielle antalffy
Steve lichtman oppenheimer
Shagun singh
Steve lichtman
Matt miksic
Margaret andrew
Larry biegelsen
Mike kratky leerink
Jereme sylvain
Joanne wuensch
Jayson bedford raymond james
Kevin sayer
Joanne wuensch citi
Medtronic (MDT) Q3 2024 Earnings Call Transcript
MDT earnings call for the period ending December 31, 2023.
United states
Ryan weispfenning
Tom holloran
Greg smith
Bob white
Vijay kumar evercore
Anthony petrone mizuho
Robbie marcus
Karen parkhill
Joanne wuensch citi
Earl bakken
Robbie marcus jpmorgan
Tom holleran
Mike marinaro
Nitron cryoconsole
Matt miksic barclays
Medtronic (MDT) Q3 2024 Earnings Call Transcript
MDT earnings call for the period ending December 31, 2023.
United states
Sean salmon
Geoff martha
Mike marinaro
Ryan weispfenning
Anthony petrone mizuho
Greg smith
Bob white
Joanne wuensch citi
Karen parkhill
Nitron cryoconsole
Robbie marcus
Earl bakken
Matt miksic barclays
Tom holleran
America merrill lynch
DexCom (DXCM) Q4 2023 Earnings Call Transcript
DXCM earnings call for the period ending December 31, 2023.
United states
New zealand
Matt miksic
America merrill lynch
Mathew blackman
Sean christensen
Margaret andrew
Kevin sayer
Larry biegelsen
Steve lichtman oppenheimer
Joanne wuensch citi
Mike kratky leerink
Matthew obrien piper sandler
Matt obrien
Jereme sylvain
Joanne wuensch
Abbott Laboratories (ABT) Q4 2023 Earnings Call Transcript
ABT earnings call for the period ending December 31, 2023.
Phil boudreau
Robert ford
Robbie marcus
Vijay kumar
Bob funck
Larry biegelsen
Robbie marcus jpmorgan
Danielle antalffy
Joanne wuensch citi
Mike comilla
Joanne wuensch
America merrill lynch
Vijay kumar evercore
Joshua jennings
Marie thibault
Abbott laboratories
vimarsana © 2020. All Rights Reserved.